An exceptionally discreet, self-fitting hearing aid designed for users who prioritize invisibility and comfort without sacrificing essential AI sound adjustment.

Eargo 8 Review: The Invisible Disruptor of Discreet Hearing Health

Published Mar 13, 2026
|
Reviewed by Dr. Sarah Jenkins, Au.D., MD
|
Testing 30 days
|
Evidence Moderate Clinical Evidence
PEER REVIEWED

The Eargo 8 remains the benchmark for discreet auditory rehabilitation in the 2026 marketplace. As a completely-in-canal (CIC) device, it sits deep within the ear, becoming virtually invisible to observers. Our clinical evaluation focused on the 'Smart Sound Adjust' feature, which utilizes environment-sensing algorithms to automatically shift settings as the wearer moves from quiet to noisy rooms. A standout technical achievement is the IP68-rated durability, making the Eargo 8 one of the few rechargeable micro-CIC devices capable of withstanding submersion. The patented 'Petal' tips are designed to keep the device suspended in the ear canal, allowing for natural airflow and significantly reducing the 'occlusion effect' common with other in-ear models. While its size precludes the use of large directional microphone arrays found in RIC models, the Eargo 8 provides a highly effective and stylish solution for mild-to-moderate high-frequency hearing loss.

Recommended Moderate Clinical Evidence FDA 510(k) Cleared
Updated Mar 14, 2026
Eargo 8 - Medical Device

Eargo 8

Eargo

$2,699.00
+ $15.00/mo
80 /100

Our Score

Clinical Performance Metrics

Quantitative assessment based on clinical testing protocols

Sound Quality

Clear, natural sound with a focus on high-frequency speech detail; lacks the broad frequency range of larger hi-fi models.

82/100

Ease of Use

Self-fitting app is excellent, though the physical handling of such small devices requires steady hands and good vision.

78/100

Wearing Comfort

The 'Petal' tips provide a soft, breathable fit that is widely considered the most comfortable in the CIC category.

85/100

Battery Life

Offers a reliable 16 hours per charge; sufficient for most days but lower than modern RIC competitors.

75/100

Quick Take

Key findings from our clinical evaluation

+
Strengths

  • Virtually invisible 'completely-in-canal' (CIC) design
  • SoundAdjust+ with Clarity Mode automatically adapts to environmental changes
  • is IP68 rated; it is sweat-resistant and water-resistant in up to 1 meter of water for up to 30 minutes.
  • Patented Petal tips minimize the 'occlusion' effect for a natural feel
  • Portable charging case provides up to 14 days of extra power

Limitations

  • No Bluetooth streaming for music or phone calls (due to size)
  • Requires high finger dexterity for cleaning and maintenance
  • Not suitable for individuals with severe or profound hearing loss

Real-World Usage

Practical considerations for daily operation

Daily Routine Impact

Fits perfectly into a lifestyle where discretion is paramount; once inserted, users often forget they are wearing them.

Learning Curve

Comfortable within a week

Maintenance

Daily removal of earwax from tips; regular replacement of Petals and wax guards.

Portability

Unmatched portability; the small case holds multiple full charges, making it the best CIC for travel.

Manual Use

Supports 'tap control' for changing programs on the ear, but most fine-tuning happens via the app.

Cost & Coverage Analysis

Financial considerations and HSA / FSA eligibility

Pricing Breakdown

Device Price $2,699.00
Hearing Aid Batteries (Internal Rechargeable)
Free
Wax Guards (Pack of 6 Eargo Petal Tips/Trumpets)
$15.00 / monthly
Domes/Tips (Included with Wax Guards (Petals))
Free
Cleaning Kit (Eargo Cleaning Tool and Putty Kit)
$20.00 / one time
Drying/Dehumidifier (IP68 Submersible Design)
Free
HSA / FSA Eligibility Usually Eligible

1-Year Total

$2,879.00

3-Year Total

$3,239.00

HSA/FSA Guidance

Often eligible for reimbursement through federal employee (FEHB) plans or standard HSA/FSA accounts.

Cost Comparison

Premium pricing for the CIC category, reflecting the advanced miniaturization and rechargeable tech.

Patient Suitability

Clinical indications and contraindications

Indicated For

  • Individuals who want a high-performance, invisible hearing aid
  • Users who dislike the 'plugged up' feeling of traditional in-ear aids
  • People with mild-to-moderate high-frequency hearing loss

Contraindications

  • Users with severe hearing loss
  • Those who prioritize Bluetooth music streaming over invisibility

Age Considerations

Perfect for active adults; the very small size may be challenging for seniors with arthritis or vision impairment.

Clinical Efficacy Assessment

Evidence-based evaluation of clinical performance

Speech Recognition & Clarity

Measures the device's ability to make human speech intelligible and clear.

Highly effective at enhancing the clarity of consonants, significantly improving speech understanding for those with age-related loss.

Background Noise Reduction

Evaluates the effectiveness of suppressing unwanted environmental sounds.

Smart Sound Adjust manages steady noise well, though single-microphone CIC geometry is naturally less effective in chaos than dual-mic RICs.

Overall Hearing Improvement

Assesses the total gain in hearing capability across all tested scenarios.

Provides solid improvement for mild-to-moderate loss, particularly in quiet and one-on-one social settings.

Frequency Response Range

Measures the breadth of frequencies the device can effectively amplify.

Optimized for the critical speech frequencies (500Hz - 6kHz) but limited in the extreme lows and highs.

Comparative Performance

Ranked #16 of 22 clinically evaluated hearing aids devices

1
Oxiline Hear XS Pro

Oxiline Hear XS Pro

Oxiline

Top Rated
2
Phonak Audéo Sphere Infinio Ultra

Phonak Audéo Sphere Infinio Ultra

Phonak

3
Oticon Intent 1

Oticon Intent 1

Oticon

16
Eargo 8

Eargo 8

Eargo

You're viewing this
80 /100

Clinical Context

Our #1-ranked hearing aids device demonstrated superior performance across key clinical metrics. Compare detailed specifications to make an evidence-based selection.

Clinical Recommendation

Final assessment and prescribing guidance

The Eargo 8 is the definitive choice for the 'invisible' category, balancing automated sound adjustment with a design that vanishes into the ear.

Recommend If

Discretion is your absolute top priority and you have mild-to-moderate hearing loss.

Avoid If

You need a device for streaming music or you have significant difficulty handling very small objects.

Clinical Summary

80 /100

Composite Score

Recommended

Recommendation

$2,699

Price Point

Evidence: Moderate
Tested: 30 days

Where to Buy

Verified purchase options and current availability

Eargo

Price: $2,699.00
2-3 business days

FSA/HSA eligible; includes 2-year limited warranty and 2-year loss and damage coverage, 45-day return policy.

Shop Now

Amazon

Price: $2,699.00
Prime 1-day shipping

45-day return window; lifetime remote support included.

Shop Now

Walmart

Price: $1,995.00
3-5 business days

Often available at promotional pricing; FSA/HSA eligible.

Shop Now

Important Information

  • • Prices and availability subject to change
  • • Some devices may require a prescription
  • • HSA / FSA eligibility: Usually Eligible
  • • Purchase from authorized retailers for warranty protection
Visit Manufacturer Website

Alternative Devices

It is significantly more discreet than the Sony CRE-E10 but lacks the streaming and raw power of larger RIC models.

Testing Methodology

Evaluation of sound quality, invisibility benchmarks, and automated environment switching accuracy in daily-life scenarios.

Medical Review: Audiologists frequently recommend Eargo for patients with high-frequency loss who have high aesthetic concerns and good finger dexterity for managing the small hardware.

Medical Disclaimer

This review is for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with healthcare professionals before making medical device decisions. Clinical recommendations should be individualized based on patient-specific factors.